NWBO

Health Care Sector Update for 12/23/2015: NWBO,ADMS,GBSN

Top Health Care Stocks

JNJ +0.83%

PZE +0.25%

MRK +1.41%

ABT +1.69%

AMGN +0.15%

Health care stocks were climbing with the broader markets this afternoon, with the NYSE Health Care Index adding around 1.1% while shares of health care companies in the S&P 500 were up about 1.0% as a group.

In company news, Northwest Biotherapeutics ( NWBO ) tumbled Wednesday after the specialty drugmaker today priced a $12.6 million direct offering of 3.5 mln shares of its common stock at $3.60 each, a 19% discount to Tuesday's closing price for the stock.

The private deal with unidentified institutional investors also included five-year warrants to buy up to 1.75 million additional shares exercisable at $4.50 a share beginning six months after their issuance.

NWBO shares fell almost 19% to $3.61, staying just 10 cents above today's session low.

In other sector news,

(+) ADMS, ADS-5102 drug candidate meets primary endpoint during Phase III testing, showing statistically significant drop in levodopa-induced dyskinesia in patients with Parkinson's disease compared with placebo after 12 weeks.

(-) GBSN, Sells 2.724 mln units consisting of one share of Series E convertible preferred stock and eight Series C warrants, each convertible into four shares of common stock and exercisable at $2.55 a share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.